8948
A. Specht et al. / Tetrahedron Letters 43 (2002) 8947–8950
hydroxyphenacyl group to mask thiol-containing
biomolecules (Scheme 1). We used an N-Bz substituted
cysteine derivative to facilitate UV detection for HPLC
analysis during the photolytic reaction.
Finally, hydrolysis of the thioester 5 gave the desired
3%-thio dTMP 6. This nucleotide monophosphate
analog was masked by treatment with p-
hydroxyphenacyl bromide using a 1/1 ethanol/HEPES
buffer mixture. Probe B was synthesized in 21% overall
yields from the lyxofuranosyl thymidine derivative 1.
Direct introduction of the p-hydroxyphenacyl group as
a protecting group by converting the mesylate 2 with
p-hydroxyphenacyl mercaptan could not be used due to
non-compatible properties of the phenacyl group with
the subsequent phosphorylation conditions.
The chemical modification of thiol-containing
molecules can be achieved by direct treatment with
p-hydroxyphenacyl bromide (Scheme 1). The coupling
yields are usually high and the reagent can be used in
1/1 ethanol/aqueous buffer (1N HEPES pH 7.0) mix-
tures for the reaction of water soluble substrates (A:
80%; B 90%; C: 92%). It should be expected that
selective modification of cysteines13 can be obtained by
direct treatment of a protein with p-hydroxyphenacyl
bromide.
The photolytic reactions of A, B and C (u=312 nm in
Tris–HCl buffer; pH 7.2) were analyzed by UV spec-
troscopy and HPLC as well as by MS for the glu-
tathione derivative C (Fig. 1). All three compounds
showed a decrease in absorbance at 290 and 340 nm
corresponding to the disappearance of the starting com-
pounds (umax 290 and 340 nm). The presence of
isobestic points at 270 nm was indicative of homoge-
neous photolytic reactions. The HPLC analyses of these
reactions depicted the formation of the unmasked thiol
derivatives, the expected side-products: p-hydroxy-
phenylacetic acid together with p-hydroxy acetophen-
one18 as well as a new compound: the p-hydroxy-
phenylacetic thioester19 derived from the biomolecules.
Table 1 summarizes the photochemical results on com-
pounds A, B and C, respectively.
3%-Thio-2%-deoxythymidine phosphate (3%-thio-dTMP)
represents a substrate analog14 for thymidilate mono
phosphate kinase (TMPK) which trans-phosphorylates
a phosphate group from ATP to dTMP forming ADP
and dTDP. The synthesis of the 3%-thio analog of
dTMP is outlined in Scheme 2. 5%-O-Methoxymethyl-
trityl-lyxofuranosyl thymidine 1 was synthesized from
thymidine using a described method.15 This four-step
synthesis ensured the desired configuration of the 3%-
thio group by two successive inversions at this position.
A thioester group (compound 3), precursor of the thiol
group, was stereospecifically introduced16 at the 3%-posi-
tion by reaction of sodium thiobenzoate with the mesyl-
ate 2. The monophosphate group was incorporated at
the 5%-OH position by reaction with phosphorus oxy-
chloride after removal of the protecting group.17
Quantum yield of the photolytic reaction for B was
determined by actinometry using azobenzene as
actinometer20 at 313 nm. A quantum yield of 0.085 for
Scheme 2. Synthesis of p-hydroxyphenacyl thioether of 3%-thio dTMP (B). Reagents and conditions: (i) MsCl, pyridine, 0°C, v22
h, z=98%; (ii) sodium thiobenzoate, DMF, 100°C, 22 h, z=55%; (iii) AcOH, rt, 24 h, z=85% ; (iv) 1. POCl3, trimethylphos-
phate, 0°C, 22 h, 2. triethylammonium formate 0.2N pH 7, 0°C 30 min and C18 HPLC reversed phase purification, z=58%; (v)
NaOH, EtOH, 0°C, 70 min, C18 HPLC reversed phase purification, z=88%; (vi) p-hydroxybromophenacyl 1N HEPES buffer pH
7/EtOH: 1/1, rt, 2 h, C18 HPLC reversed phase purification, z=90%.